300294.SZ
Price:
$23.17
Market Cap:
$11.68B
China Resources Boya Bio-pharmaceutical Group Co., Ltd. engages in the blood products, diabetes medication, biochemical medication, and chemical medicine businesses in China. It engages in the research and development, production, and sales of blood products comprising human fibrinogen, intravenous human immunoglobulin, rabies immunoglobulin, human albumin, human immunoglobulin, freeze-dried intravenous human immunoglobulin, and hepatitis B human immunoglobulin; diabetes products, including metformin hydrochloride tablets/enteric-coated tablets, pioglitazone hydrochloride dispersible tablets, glimepiride tablets, and calcium dobesilate capsules; and compound osteotide, oxytocin, and heparin ...[Read more]
Industry
Biotechnology
IPO Date
2012-03-08
Stock Exchange
SHZ
Ticker
300294.SZ
According to China Resources Boya Bio-pharmaceutical Group Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 11.19B. This represents a change of -12.32% compared to the average of 12.76B of the last 4 quarters.
The mean historical Enterprise Value of China Resources Boya Bio-pharmaceutical Group Co., Ltd. over the last ten years is 12.88B. The current 11.19B Enterprise Value has changed 8.59% with respect to the historical average. Over the past ten years (40 quarters), 300294.SZ's Enterprise Value was at its highest in in the December 2021 quarter at 17.79B. The Enterprise Value was at its lowest in in the December 2015 quarter at 8.67B.
Average
12.88B
Median
13.61B
Minimum
8.27B
Maximum
16.94B
Discovering the peaks and valleys of China Resources Boya Bio-pharmaceutical Group Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 98.05%
Maximum Annual Enterprise Value = 16.94B
Minimum Annual Increase = -19.81%
Minimum Annual Enterprise Value = 8.27B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 13.98B | -5.73% |
| 2023 | 14.83B | -12.47% |
| 2022 | 16.94B | 11.61% |
| 2021 | 15.18B | 9.48% |
| 2020 | 13.86B | 3.74% |
| 2019 | 13.36B | 32.00% |
| 2018 | 10.12B | -19.81% |
| 2017 | 12.63B | 31.24% |
| 2016 | 9.62B | 16.33% |
| 2015 | 8.27B | 98.05% |
The current Enterprise Value of China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
15.25B
5-year avg
14.96B
10-year avg
12.88B
China Resources Boya Bio-pharmaceutical Group Co., Ltd.’s Enterprise Value is less than Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (14.32B), greater than Hualan Biological Bacterin Inc. (10.67B), less than Zhejiang Jolly Pharmaceutical Co.,LTD (11.75B), less than Tibet Cheezheng Tibetan Medicine Co., Ltd. (13.82B), less than Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (14.37B), greater than Shanghai Haohai Biological Technology Co., Ltd. (6.45B), less than Jinyu Bio-technology Co., Ltd. (15.34B), greater than Chengdu Easton Biopharmaceuticals Co., Ltd. (9.67B), greater than Sansure Biotech Inc. (8.26B), greater than Chengdu Kanghua Biological Products Co., Ltd. (8.90B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 14.32B | $12.35B | |
| 10.67B | $11.50B | |
| 11.75B | $11.63B | |
| 13.82B | $13.03B | |
| 14.37B | $11.40B | |
| 6.45B | $8.53B | |
| 15.34B | $16.64B | |
| 9.67B | $10.08B | |
| 8.26B | $11.01B | |
| 8.90B | $9.69B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like China Resources Boya Bio-pharmaceutical Group Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like China Resources Boya Bio-pharmaceutical Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is China Resources Boya Bio-pharmaceutical Group Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)?
What is the 3-year average Enterprise Value for China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)?
What is the 5-year average Enterprise Value for China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)?
How does the current Enterprise Value for China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) compare to its historical average?